PT-141 Dosage Calculator
Reconstitution volumes, concentration and U-100 unit equivalents for PT-141.
These examples explain unit relationships in published research and are not instructions for preparing, measuring or administering any compound. Do not use this information to self-administer research chemicals.
Worked at 1.75 mg, the amount reported in the research for PT-141. Every row is the same arithmetic: milligrams in the vial divided by millilitres of water gives the concentration, and the target amount divided by that concentration gives the volume.
10 mg vial of PT-141
| Water added | Concentration | Volume for 1.75 mg | Units (U-100) |
|---|---|---|---|
| 1.0 mL | 10.00 mg/mL | 0.17 mL | 18 u |
| 2.0 mL | 5.00 mg/mL | 0.35 mL | 35 u |
| 3.0 mL | 3.33 mg/mL | 0.53 mL | 53 u |
As needed before activity, subcutaneous. For research reference only, not medical advice.
| Phase | Amount |
|---|---|
| As needed | 1.75 mg, up to 45 min before |
No more than one dose per 24 hours or eight per month, per the approved label.
How strong is the evidence for PT-141?
We grade it A on a four-point scale. Phase 3 data. Approved as Vyleesi.
What is the half-life of PT-141?
About 2.7 hours. That is the figure the reported dosing frequency follows from.
What amount of PT-141 is used in the research?
As needed: 1.75 mg, up to 45 min before. No more than one dose per 24 hours or eight per month, per the approved label.
How is PT-141 stored once reconstituted?
Refrigerate the mixed vial at 2 to 8 °C, use within a few weeks and avoid freeze and thaw.
Mechanism, benefits and side effects in the research, evidence grade, storage, third-party testing and the reference studies behind these amounts.
Open the PT-141 reference →